Rare diseases
Investigational molecules
Locations
Back to Poland120 clinical trials in Elblag, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
PolandStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
PolandStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PolandStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
PolandStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
PolandThe busiest research cities in the country
What the registry says about research in the country
Research focusing on plaque psoriasis and innovative treatments for moderate to severe cases. Studies evaluating novel therapeutic approaches for atopic dermatitis.
Multiple trials investigating long-term safety and efficacy of new therapeutic agents.
Comprehensive research into psoriatic arthritis treatments, including studies for both biologic-naive and experienced patients. Additional focus on Sjögren's Syndrome and innovative therapies.
Evaluating multiple therapeutic approaches for autoimmune conditions.
Studies addressing obesity and weight management through innovative treatments. Research on respiratory conditions including RSV infections and asthma management.
Focus on both preventive measures and therapeutic interventions.
Investigations into treatments for Crohn's Disease and Ulcerative Colitis, focusing on innovative therapeutic approaches for inflammatory bowel conditions.
Evaluating new therapeutic options for inflammatory bowel diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
